Since the start of the Covid-19 pandemic, there has been a 23% increase in alcohol abuse and a 16% increase in drug abuse, and people in self-isolation reported a 26% higher consumption than usual, according to the National Library of Medicine. Some apps are trying to meet this need, including Sober Sidekick and SoberBuddy.
G1 Therapeutics said its drug met the main goal of a Phase 3 study in colorectal cancer, but the preliminary results also show measures of survival are better in the placebo arm. The company is stopping the colorectal cancer study.
The funding round was led by Distributed Ventures and included participation from Idealab NY and Elements Health Ventures. Tuned plans to use the funding to contract with more employers and third party administrators, said Danny Aronson, co-founder and CEO of the startup.
Intermountain Health recently struck a partnership with experience management company Qualtrics. The Salt Lake City-based health system is implementing Qualtrics' platform across all its facilities to optimize research around the customer and employee experience.
GE HealthCare recently announced plans to acquire Caption Health, a company that sells AI software designed to guide cardiac imaging. The company's guidance technology aims to make ultrasound exams easier and faster, as well as allow a broader set of healthcare professionals to conduct basic echocardiography exams.
Frequency Therapeutics said its hearing loss drug candidate failed to beat a placebo in its second mid-stage clinical trial. The biotech is now focusing its regenerative medicine platform on the development of a multiple sclerosis drug not expected to reach the clinic until next year.
The deficiency of nurse-specific billing data makes nurses literally and figuratively invisible in terms of political and financial decision-making capacity within the U.S. healthcare sector.
No comments